ijms-logo

Journal Browser

Journal Browser

Gestational Diabetes Mellitus: Molecular Insights into Pathophysiology, Management and Therapy

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 20 September 2025 | Viewed by 417

Special Issue Editor


E-Mail Website
Guest Editor
1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-015 Warsaw, Poland
Interests: diabetes in pregnancy; fetal growth disorders; placenta; biomarkers; ultrasound

Special Issue Information

Dear Colleagues,

It has been more than 50 years since J. Pedersen proposed the hypothesis according to which hyperglycemia associated with diabetes in pregnancy triggers a cascade of events leading to fetal hyperinsulinemia, and as a result excessive fetal growth. Gestational diabetes mellitus (GDM) constitutes one of the forms of impaired glucose tolerance and is diagnosed for the first time during pregnancy. The condition occurs in ca. 5-15% of pregnant women, mostly predisposed, and is associated with multiple maternal-fetal complications including fetal macrosomia, preeclampsia and polyhydramnios. Moreover, existing evidence suggests the effects of GDM extend beyond the gestation period for both the mother and child, hence implicating it's role in future health programming. It is, therefore, obvious that genetic mechanisms play an important role in GDM pathogenesis and occurrence of certain diabetic complications. Gene mutations, post-transcriptional and post-translational modifications are some of the examples of alterations underlying pathologies present in GDM, patient’s responsiveness to therapy as well as maternal-fetal health programming.

This Special Issue is dedicated to all those above-mentioned changes observed on the molecular level and associated with diabetic environment in pregnancy. Original and review papers evaluating the role of genetics in GDM are welcome.

Dr. Paweł Jan Stanirowski
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • GDM pathogenesis
  • health programming
  • pharmacogenomics
  • life-style interventions
  • fetal growth disorders
  • preeclampsia
  • polyhydramnios
  • placental origin of disease

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 627 KiB  
Review
Investigating the Role of Skin Autofluorescence in Gestational Diabetes Mellitus: A Systematic Review
by Bianca-Margareta Salmen, Delia Reurean-Pintilei, Dan Trofin, Cristiana-Elena Durdu, Alexandra-Cristina Neagu and Roxana-Elena Bohiltea
Int. J. Mol. Sci. 2025, 26(7), 3022; https://doi.org/10.3390/ijms26073022 - 26 Mar 2025
Viewed by 250
Abstract
Gestational diabetes mellitus (GDM) is a pregnancy-specific condition that can cause serious complications for both the mother and the fetus. Preventing these complications requires optimum glycemic control. Skin autofluorescence (SAF) is a non-invasive and innovative method that evaluates the levels of advanced glycation [...] Read more.
Gestational diabetes mellitus (GDM) is a pregnancy-specific condition that can cause serious complications for both the mother and the fetus. Preventing these complications requires optimum glycemic control. Skin autofluorescence (SAF) is a non-invasive and innovative method that evaluates the levels of advanced glycation end products, markers of hyperglycemia, that could aid in the optimum management of GDM-complicated pregnancies. This systematic review aims to assess SAF’s potential utility in the prediction of short-term and long-term outcomes in GDM. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology, with the protocol identifier CRD42024559012, we used “(skin autofluorescence OR SAF) AND (gestational diabetes mellitus OR GDM)” as a search criterion on the PubMed, Scopus, and Web of Science databases. After a rigorous selection process, we included five articles, which evaluated SAF values and GDM, SAF and pregnancies complicated by diabetes mellitus, and SAF and macrosomia. GDM diagnosis varies due to the different approaches among the major guidelines, leading to variations in interpretation and diagnostic thresholds. Across studies, this variability contributes to inconsistent SAF values. As a standardized and objective marker, SAF could provide a uniform criterion, improving GDM management. Further research is needed to validate its clinical utility. Full article
Show Figures

Figure 1

Back to TopTop